Patents by Inventor Shalina Sheryl Ousman

Shalina Sheryl Ousman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Alpha B-Crystallin as a Therapy for Ischemia or Inflammation
    Publication number: 20150079083
    Abstract: The invention provides methods for treating inflammatory diseases by administering to the subject an effective amount of an agent that provides alpha B-crystallin activity, where the dose is effective to suppress or prevent initiation, progression, or relapses of disease, including the progression of established disease. In some embodiments, the methods of the invention comprise administering to a subject having a pre-existing inflammatory disease condition, an effective amount of alpha B-crystallin protein, to suppress or prevent relapses of the disease.
    Type: Application
    Filed: July 7, 2014
    Publication date: March 19, 2015
    Inventors: Lawrence Steinman, Shalina Sheryl Ousman, William H. Robinson
  • Alpha B-crystallin as a therapy for multiple sclerosis
    Patent number: 8835391
    Abstract: The invention provides methods for treating inflammatory diseases by administering to the subject an effective amount of an agent that provides alpha B-crystallin activity, where the dose is effective to suppress or prevent initiation, progression, or relapses of disease, including the progression of established disease. In some embodiments, the methods of the invention comprise administering to a subject having a pre-existing inflammatory disease condition, an effective amount of alpha B-crystallin protein, to suppress or prevent relapses of the disease.
    Type: Grant
    Filed: January 21, 2011
    Date of Patent: September 16, 2014
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Lawrence Steinman, Shalina Sheryl Ousman, William H. Robinson
  • Alpha B-crystallin as a therapy for ischemia or inflammation
    Patent number: 8771689
    Abstract: The invention provides methods for treating inflammatory diseases by administering to the subject an effective amount of an agent that provides alpha B-crystallin activity, where the dose is effective to suppress or prevent initiation, progression, or relapses of disease, including the progression of established disease. In some embodiments, the methods of the invention comprise administering to a subject having a pre-existing inflammatory disease condition, an effective amount of alpha B-crystallin protein, to suppress or prevent relapses of the disease.
    Type: Grant
    Filed: June 23, 2011
    Date of Patent: July 8, 2014
    Assignees: The Board of Trustees of the Leland Stanford Junior University, Department of Veterans Affairs
    Inventors: Lawrence Steinman, Shalina Sheryl Ousman, William H. Robinson
  • Alpha B-crystallin as a therapy for Ischemia or inflammation
    Publication number: 20110318346
    Abstract: The invention provides methods for treating inflammatory diseases by administering to the subject an effective amount of an agent that provides alpha B-crystallin activity, where the dose is effective to suppress or prevent initiation, progression, or relapses of disease, including the progression of established disease. In some embodiments, the methods of the invention comprise administering to a subject having a pre-existing inflammatory disease condition, an effective amount of alpha B-crystallin protein, to suppress or prevent relapses of the disease.
    Type: Application
    Filed: June 23, 2011
    Publication date: December 29, 2011
    Inventors: Lawrence Steinman, Shalina Sheryl Ousman, William H. Robinson
  • Alpha B-Crystallin as a therapy for inflammation
    Publication number: 20110160142
    Abstract: The invention provides methods for treating inflammatory diseases by administering to the subject an effective amount of an agent that provides alpha B-crystallin activity, where the dose is effective to suppress or prevent initiation, progression, or relapses of disease, including the progression of established disease. In some embodiments, the methods of the invention comprise administering to a subject having a pre-existing inflammatory disease condition, an effective amount of alpha B-crystallin protein, to suppress or prevent relapses of the disease.
    Type: Application
    Filed: January 21, 2011
    Publication date: June 30, 2011
    Inventors: Lawrence Steinman, Shalina Sheryl Ousman, William H. Robinson
  • Alpha B-crystallin as a therapy for rheumatoid arthritis
    Patent number: 7875589
    Abstract: The invention provides methods for treating inflammatory diseases by administering to the subject an effective amount of an agent that provides alpha B-crystallin activity, where the dose is effective to suppress or prevent initiation, progression, or relapses of disease, including the progression of established disease. In some embodiments, the methods of the invention comprise administering to a subject having a pre-existing inflammatory disease condition, an effective amount of alpha B-crystallin protein, to suppress or prevent relapses of the disease.
    Type: Grant
    Filed: December 11, 2007
    Date of Patent: January 25, 2011
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Lawrence Steinman, Shalina Sheryl Ousman, William H. Robinson
  • Alpha b-chrystallin as a therapy for inflammation
    Publication number: 20080138353
    Abstract: The invention provides methods for treating inflammatory diseases by administering to the subject an effective amount of an agent that provides alpha B-crystallin activity, where the dose is effective to suppress or prevent initiation, progression, or relapses of disease, including the progression of established disease. In some embodiments, the methods of the invention comprise administering to a subject having a pre-existing inflammatory disease condition, an effective amount of alpha B-crystallin protein, to suppress or prevent relapses of the disease.
    Type: Application
    Filed: December 11, 2007
    Publication date: June 12, 2008
    Inventors: Lawrence Steinman, Shalina Sheryl Ousman, William H. Robinson